Fingerprint
Dive into the research topics where Peng Zhang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Oncogenic activation of EVC/EVC2 defines a therapeutically targetable subset of acute myeloid leukemia
Sui, P., Li, Y., Hong, J., Delma, C. R., Chen, S., Wang, J., Zhang, P., Han, S., Noor, A., Yang, H., Pang, Y., Luan, Y., Xu, M., Lee, J. & Yang, F. C., Jan 2026, In: Leukemia. 40, 1, p. 166-177 12 p.Research output: Contribution to journal › Article › peer-review
-
Phf6 truncating mutation drives leukemogenesis via disrupted epigenetic regulation in mice
Guo, Y., Sui, P., Yang, H., Zhu, G., Li, Y., Chen, S., Zhao, Y., Ge, G., Eisa, Y. A., Delma, C. R., Medina, E. A., Zhang, P., Lee, J., Xu, M. & Yang, F. C., Mar 2026, In: Leukemia. 40, 3, p. 594-608 15 p.Research output: Contribution to journal › Article › peer-review
-
PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1
Hong, J., Sui, P., Li, Y., Xu, K. Y., Lee, J. H., Wang, J., Chen, S., Zhang, P., Wingate, N., Noor, A., Yuan, Y., Hromas, R., Zhou, H., Hamamoto, K., Su, R., Yin, C. C., Ye, F., Quesada, A. E., Chen, J. & Huang, S. & 5 others, , Mar 6 2025, In: Cell Stem Cell. 32, 3, p. 463-478.e6Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations -
SRSF2 mutation cooperates with ASXL1 truncated alteration to accelerate leukemogenesis
Sui, P., Ge, G., Chen, S., Bai, J., Rubalcava, I. P., Yang, H., Guo, Y., Zhang, P., Li, Y., Medina, E. A., Xu, M., Abdel-Wahab, O., Bradley, R. & Yang, F. C., Feb 2024, In: Leukemia. 38, 2, p. 408-411 4 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Scopus citations -
Targeting lysine demethylase 6B ameliorates ASXL1 truncation–mediated myeloid malignancies in preclinical models
Ge, G., Zhang, P., Sui, P., Chen, S., Yang, H., Guo, Y., Rubalcava, I. P., Noor, A., Delma, C. R., Agosto-Peña, J., Geng, H., Medina, E. A., Liang, Y., Nimer, S. D., Mesa, R., Abdel-Wahab, O., Xu, M. & Yang, F. C., Jan 20 2024, In: Journal of Clinical Investigation. 134, 1, e163964.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations